Sanjivani Paranteral Limited. (SANJIVIN.BO)
INR 250.05
(6.84%)
INR 250.05
(6.84%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 64.47 Million INR | 474.11% |
| 2022 | -19.53 Million INR | -160.07% |
| 2021 | 32.51 Million INR | 257.08% |
| 2020 | 9.1 Million INR | 153.92% |
| 2019 | -16.89 Million INR | 53.76% |
| 2018 | -36.52 Million INR | 93.15% |
| 2017 | -533.39 Million INR | -205.52% |
| 2016 | -174.58 Million INR | -16.69% |
| 2015 | -149.61 Million INR | -439.16% |
| 2014 | -27.75 Million INR | -191.41% |
| 2013 | 30.35 Million INR | -20.02% |
| 2012 | 37.95 Million INR | 16.14% |
| 2011 | 32.68 Million INR | -7.41% |
| 2010 | 35.29 Million INR | -43.46% |
| 2009 | 62.43 Million INR | 36.38% |
| 2008 | 45.77 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 27.07 Million INR | 22.82% |
| 2024 Q1 | 22.04 Million INR | 14.78% |
| 2023 Q4 | 19.2 Million INR | 11.42% |
| 2023 FY | 73.07 Million INR | 474.11% |
| 2023 Q1 | 17.82 Million INR | 48.82% |
| 2023 Q2 | 18.81 Million INR | 5.59% |
| 2023 Q3 | 17.23 Million INR | -8.42% |
| 2022 FY | -19.53 Million INR | -160.07% |
| 2022 Q4 | 11.97 Million INR | 72.02% |
| 2022 Q3 | 6.96 Million INR | -23.96% |
| 2022 Q1 | 19.4 Million INR | 32.5% |
| 2022 Q2 | 9.15 Million INR | -52.81% |
| 2021 Q2 | 10.68 Million INR | 82.01% |
| 2021 Q4 | 14.64 Million INR | -15.33% |
| 2021 FY | 32.51 Million INR | 257.08% |
| 2021 Q1 | 5.86 Million INR | -52.48% |
| 2021 Q3 | 17.29 Million INR | 61.88% |
| 2020 Q3 | 2.83 Million INR | -1.63% |
| 2020 FY | 9.1 Million INR | 153.92% |
| 2020 Q1 | -4.44 Million INR | -2277.18% |
| 2020 Q4 | 12.35 Million INR | 335.47% |
| 2020 Q2 | 2.88 Million INR | 164.82% |
| 2019 Q2 | -2.85 Million INR | 35.38% |
| 2019 Q4 | 204.3 Thousand INR | 103.49% |
| 2019 FY | -16.89 Million INR | 53.76% |
| 2019 Q1 | -4.42 Million INR | -416.55% |
| 2019 Q3 | -5.85 Million INR | -104.87% |
| 2018 Q3 | -6.98 Million INR | 45.9% |
| 2018 Q2 | -12.9 Million INR | -2589.17% |
| 2018 Q1 | -480 Thousand INR | 99.76% |
| 2018 FY | -36.52 Million INR | 93.15% |
| 2018 Q4 | -855.67 Thousand INR | 87.75% |
| 2017 Q1 | -64.39 Million INR | 36.7% |
| 2017 FY | -533.39 Million INR | -205.52% |
| 2017 Q2 | -247.1 Million INR | -283.73% |
| 2017 Q3 | -19.61 Million INR | 92.06% |
| 2017 Q4 | -200.27 Million INR | -921.02% |
| 2016 Q1 | -10.11 Million INR | 93.82% |
| 2016 FY | -174.58 Million INR | -16.69% |
| 2016 Q4 | -101.73 Million INR | -427.35% |
| 2016 Q3 | -19.29 Million INR | 14.39% |
| 2016 Q2 | -22.53 Million INR | -122.8% |
| 2015 Q1 | 2.19 Million INR | 105.55% |
| 2015 FY | -149.61 Million INR | -439.16% |
| 2015 Q4 | -163.68 Million INR | -5002.31% |
| 2015 Q3 | 3.33 Million INR | -60.86% |
| 2015 Q2 | 8.53 Million INR | 287.99% |
| 2014 Q3 | 1.3 Million INR | 1.71% |
| 2014 FY | -27.75 Million INR | -191.41% |
| 2014 Q4 | -39.59 Million INR | -3134.02% |
| 2014 Q1 | 9.25 Million INR | 293.84% |
| 2014 Q2 | 1.28 Million INR | -86.14% |
| 2013 Q3 | 18.11 Million INR | 261.27% |
| 2013 Q4 | 2.34 Million INR | -87.03% |
| 2013 FY | 30.35 Million INR | -20.02% |
| 2013 Q1 | 4.88 Million INR | -99.81% |
| 2013 Q2 | 5.01 Million INR | 2.75% |
| 2012 Q2 | 727 Thousand INR | -92.01% |
| 2012 FY | 37.95 Million INR | 16.14% |
| 2012 Q1 | 9.1 Million INR | -42.24% |
| 2012 Q4 | 2.6 Billion INR | 358815.49% |
| 2012 Q3 | 727 Thousand INR | 0.0% |
| 2011 Q3 | 10.14 Million INR | 0.0% |
| 2011 FY | 32.68 Million INR | -7.41% |
| 2011 Q4 | 15.75 Million INR | 55.41% |
| 2010 FY | 35.29 Million INR | -43.46% |
| 2009 FY | 62.43 Million INR | 36.38% |
| 2008 FY | 45.77 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DECIPHER LABS LIMITED | 53.74 Million INR | -19.968% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 92.451% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -709.121% |
| MedPlus Health Services Limited | 1.31 Billion INR | 95.115% |
| ANG Lifesciences India Limited | 12.8 Million INR | -403.481% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 16.888% |
| Bacil Pharma Limited | -1.89 Million INR | 3503.336% |
| BDH Industries Limited | 169.01 Million INR | 61.855% |
| Beryl Drugs Limited | 14.73 Million INR | -337.624% |
| Cian Healthcare Limited | 53.96 Million INR | -19.459% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | -292.277% |
| Concord Drugs Limited | 24.87 Million INR | -159.21% |
| Deccan Health Care Limited | 185.32 Million INR | 65.213% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -617.138% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -12023.119% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 90.364% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 270.752% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 87.124% |
| Makers Laboratories Limited | -34.91 Million INR | 284.677% |
| Medi-Caps Limited | -17.21 Million INR | 474.612% |
| Panchsheel Organics Limited | 288.28 Million INR | 77.637% |
| Parmax Pharma Limited | 3.75 Million INR | -1617.136% |
| Parnax Lab Limited | 166.84 Million INR | 61.359% |
| Patidar Buildcon Limited | -1.83 Million INR | 3611.479% |
| Phaarmasia Limited | - INR | -Infinity% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 81.008% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 15979.495% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | -88.759% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 70.108% |
| Trident Lifeline Limited | 72.21 Million INR | 10.719% |
| Transchem Limited | -17.43 Million INR | 469.693% |
| Trinity League India Limited | 1.17 Million INR | -5396.227% |
| Tyche Industries Limited | 111.22 Million INR | 42.035% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 735.368% |
| Vivanza Biosciences Limited | 14.83 Million INR | -334.673% |
| PRAVEG LIMITED | 185.06 Million INR | 65.164% |
| Sastasundar Ventures Limited | -229.64 Million INR | 128.074% |
| Sunil Healthcare Limited | -19.98 Million INR | 422.66% |
| Syschem (India) Limited | 504.91 Million INR | 87.231% |
| Zenith Healthcare Limited | 196 Thousand INR | -32793.239% |
| Zenlabs Ethica Limited | 89.27 Million INR | 27.786% |
| Mercury Laboratories Limited | 62.14 Million INR | -3.737% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 34.661% |
| Vasundhara Rasayans Limited | 61.27 Million INR | -5.214% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 140.276% |
| Roopa Industries Limited | 48.05 Million INR | -34.155% |
| PANJON LTD. | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 143.179% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 459.83% |
| Anuh Pharma Limited | 682.19 Million INR | 90.55% |
| Crestchem Limited | 27.25 Million INR | -136.539% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 648.454% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | -276.472% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 82.301% |
| Trimurthi Limited | -6.14 Million INR | 1149.493% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 72.712% |
| Norris Medicines Limited | 11.15 Million INR | -477.842% |
| Veerhealth Care Limited | 34.19 Million INR | -88.555% |
| Lactose (India) Limited | 137.78 Million INR | 53.21% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 152.173% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 85.24% |
| Gennex Laboratories Limited | 146.61 Million INR | 56.028% |
| Denis Chem Lab Limited | 142.87 Million INR | 54.877% |
| Colinz Laboratories Limited | 14.64 Million INR | -340.284% |
| Godavari Drugs Limited | -67.67 Million INR | 195.271% |
| Zenotech Laboratories Limited | 242.37 Million INR | 73.401% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 88.739% |
| Bharat Parenterals Limited | 733.49 Million INR | 91.21% |
| Coral Laboratories Limited | 142.63 Million INR | 54.8% |
| Evoq Remedies Limited | 42.91 Million INR | -50.222% |
| Kerala Ayurveda Limited | 48.04 Million INR | -34.185% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 2699.627% |
| Natural Capsules Limited | 112.4 Million INR | 42.642% |
| Auro Laboratories Limited | 95.77 Million INR | 32.685% |